Featured Posts
Blog
More Good News on the Road to Ending the Pandemic
A new study from the Center for Disease Control and Prevention, which shows that a single dose of either the Pfizer-BioNTech or the Moderna…
Blog
Prescription Drug Price Controls are a Trump Legacy Worth Eradicating
During his first month in office, President Biden has seemingly been more interested in eradicating Donald Trump’s legacy than pushing his own proposals, though…
Blog
Employers Will Pay Workers to Get a Covid-19 Vaccine
The federal government, through Operation Warp speed, helped develop and bring to market vaccines against the new disease COVID-19 in less than a year, an…
Search Posts
Blog
New Drug Price Proposal Light on Competition, Heavy on Bureaucracy
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs.
Blog
RealClear Radio Hour: American Indian, EpiPen, and Free Speech Fiascos
In this episode of RealClear Radio Hour, we discuss the fiascos of government overreach and overregulation—on American Indian reservations, in the EpiPen saga, and with…
Blog
CEI Files Opening Brief in “Vapes on a Plane” Lawsuit
Today, CEI filed its opening brief against the U.S. Department of Transportation (DOT), Office of the Secretary of Transportation’s March final rule prohibiting electronic cigarette…
Blog
Q&A on the FDA’s New E-Cigarette Rules
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette…
Blog
RealClear Radio Hour: War on Cancer
In this week’s episode of RealClear Radio Hour, we tackle the war on cancer. Disruptive innovators, Stephen Bonner and Paul Davies, confront bureaucracy and big…
Blog
Deflate Drug Prices by Reforming the FDA
This Wednesday, the Senate Select Committee on Aging will hold a hearing on “sudden price spikes” among certain off-patent drugs. The most widely publicized of these…